Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Short-term Investments (2019 - 2025)

Outset Medical (OM) has disclosed Short-term Investments for 7 consecutive years, with $133.9 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments rose 286.32% to $133.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $133.9 million through Dec 2025, up 286.32% year-over-year, with the annual reading at $133.9 million for FY2025, 286.32% up from the prior year.
  • Short-term Investments for Q4 2025 was $133.9 million at Outset Medical, down from $142.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $214.3 million in Q4 2022, with the low at $25.7 million in Q1 2021.
  • Average Short-term Investments over 5 years is $147.7 million, with a median of $150.8 million recorded in 2024.
  • The sharpest move saw Short-term Investments surged 689.73% in 2021, then plummeted 74.28% in 2024.
  • Over 5 years, Short-term Investments stood at $157.1 million in 2021, then surged by 36.36% to $214.3 million in 2022, then tumbled by 37.08% to $134.8 million in 2023, then tumbled by 74.28% to $34.7 million in 2024, then soared by 286.32% to $133.9 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $133.9 million, $142.2 million, and $144.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.